In the latest episode of Health Law Diagnosed, host Bridgette Keller discusses the new Massachusetts Health Care Market Review Law and what this means for health care providers, investors, and other key stakeholders. She is joined by Member Deborah Daccord, Of Counsel, Cassie Paolillo, and Of Counsel Kate Stewart, who share their insights on the law’s far-reaching implications, including:
1. An overview of the Massachusetts Health Care Review Law and its implications
2. Key takeaways for health care entities
3. Upcoming HPC guidance and how it will affect health care transactions
4. Expanded oversight and new authorities for Massachusetts health care agencies
5. Financial assessments for health care entities
6. Regulatory considerations and potential delays for health care transactions
Have questions or want to connect with the team? Reach out to us at healthlawdiagnosed@mintz.com.
All content for Health Law Diagnosed is the property of Mintz and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In the latest episode of Health Law Diagnosed, host Bridgette Keller discusses the new Massachusetts Health Care Market Review Law and what this means for health care providers, investors, and other key stakeholders. She is joined by Member Deborah Daccord, Of Counsel, Cassie Paolillo, and Of Counsel Kate Stewart, who share their insights on the law’s far-reaching implications, including:
1. An overview of the Massachusetts Health Care Review Law and its implications
2. Key takeaways for health care entities
3. Upcoming HPC guidance and how it will affect health care transactions
4. Expanded oversight and new authorities for Massachusetts health care agencies
5. Financial assessments for health care entities
6. Regulatory considerations and potential delays for health care transactions
Have questions or want to connect with the team? Reach out to us at healthlawdiagnosed@mintz.com.
In the latest episode of Health Law Diagnosed, host Bridgette Keller discusses the new Massachusetts Health Care Market Review Law and what this means for health care providers, investors, and other key stakeholders. She is joined by Member Deborah Daccord, Of Counsel, Cassie Paolillo, and Of Counsel Kate Stewart, who share their insights on the law’s far-reaching implications, including:
1. An overview of the Massachusetts Health Care Review Law and its implications
2. Key takeaways for health care entities
3. Upcoming HPC guidance and how it will affect health care transactions
4. Expanded oversight and new authorities for Massachusetts health care agencies
5. Financial assessments for health care entities
6. Regulatory considerations and potential delays for health care transactions
Have questions or want to connect with the team? Reach out to us at healthlawdiagnosed@mintz.com.
